Development of a Manufacturing Process toward the Convergent Synthesis of the COVID-19 Antiviral Ensitrelvir
Main Authors: | Takahiro Kawajiri, Akihito Kijima, Atsuhiro Iimuro, Eisaku Ohashi, Katsuya Yamakawa, Kazushi Agura, Kengo Masuda, Kensuke Kouki, Koji Kasamatsu, Shuichi Yanagisawa, Sho Nakashima, Setsuya Shibahara, Takashi Toyota, Takafumi Higuchi, Takahiro Suto, Tadashi Oohara, Toshikatsu Maki, Naoto Sahara, Nobuaki Fukui, Hisayuki Wakamori, Hidaka Ikemoto, Hiroaki Murakami, Hiroyasu Ando, Masahiro Hosoya, Mizuki Sato, Yusuke Suzuki, Yuta Nakagawa, Yuto Unoh, Yoichi Hirano, Yoshitomo Nagasawa, Satoshi Goda, Takafumi Ohara, Takayuki Tsuritani |
---|---|
Format: | Article |
Language: | English |
Published: |
American Chemical Society
2023-04-01
|
Series: | ACS Central Science |
Online Access: | https://doi.org/10.1021/acscentsci.2c01203 |
Similar Items
-
In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir
by: Maki Kiso, et al.
Published: (2023-07-01) -
Molecular mechanism of ensitrelvir inhibiting SARS-CoV-2 main protease and its variants
by: Mengmeng Lin, et al.
Published: (2023-07-01) -
Case report: Ensitrelvir for treatment of persistent COVID-19 in lymphoma patients: a report of two cases
by: Chiho Furuya, et al.
Published: (2024-01-01) -
Effect of Renal Impairment on Pharmacokinetics and Safety of Ensitrelvir, a SARS-CoV-2 3CL Protease Inhibitor
by: Takayuki Katsube, et al.
Published: (2024-03-01) -
Pharmacokinetic and Pharmacodynamic Analysis of the 3CL Protease Inhibitor Ensitrelvir in a SARS-CoV-2 Infection Mouse Model
by: Keita Fukao, et al.
Published: (2023-10-01)